Global Hospital Acquired Infection Treatment Market – Overview
Hospital-acquired infections which are also known as healthcare-associated infections (HAI), are nosocomially acquired infections and usually acquired after hospitalization and manifest 48 hours after admission to the hospital. The risk of getting hospital-acquired infection is based on the infection control practices at the particular facilities, the patient’s immune status, and the prevalence of the various pathogens in the particular community. Various risk factors for hospital-acquired infections include factors like length of the stay of the patient in the hospital, frequency of the visit to the facility, immunosuppression, older age, stay at ICU, etc. Some major hospital-acquired infections include respiratory tract infections (pneumonia), surgical site infections, sepsis, clostridium difficile infections (CDIs), and urinary tract infections. Methicillin-resistant Staphylococcus aureus (MRSA), and pseudomonas aeruginosa are the most common cause of pneumonia. Hospital-acquired pneumonia often develops in patients who are incubated in an intensive care unit (ICU) which is also called ventilator-associated pneumonia (VAP)
Surgical site infections (SSIs) are about 20% cause of all healthcare-associated infections. A surgical site infection ranges from spontaneously limited wound discharge within 7 to 10 days of an operation. Thus, the treatment for this infection is a crucial aspect of the health of the patient. Management of hospital-acquired disease includes standard goal-directed therapies, antibiotics, fluid resuscitation, and close monitoring for organ dysfunction. Antibiotics should be selected based on the type and risk factors for MDR pathogens and the clinical stability of the patient.
Global Hospital-Acquired Infection Treatment Market – Competitive Insight
On November 17, 2023, Novant Heath acquired three hospitals from Tenet Healthcare.
On October 31, 2023, Tabula Rasa Healthcare stockholders approved the acquisition by Nautic partner.
Some of the Key Players in the Global Hospital Acquired Infection Treatment Market Include –
Global Hospital Acquired Infection Treatment Market – Growth Drivers
According to a report by WHO, the impact of healthcare-associated infections and antimicrobial resistance on people’s lives is huge. Over 24% of patients affected by healthcare-associated sepsis and 52.3% of those patients treated in an ICU (Intensive Care Unit) die each year. Thus the high prevalence of hospital-acquired infection throughout the world is the major driver for the global hospital-acquired infection treatment market. An increase in the geriatric population indirectly leads to more instances of hospital-acquired infection. According to a WHO report, 1 in every 6 people in the world will be geriatric by the end of the year 2030. This provides opportunities for growth in a particular segment of the market. There has been an increase in the emphasis on patient safety and quality healthcare facilities thus there is a rise in the demand on the treatment of hospital-acquired infection treatment making it another growth driver for the particular market. Emerging healthcare facilities in developing nations are another key factor that contributes to the growth of the global hospital-acquired infection treatment market. According to WHO, in low and medium-income countries, 11$ of patient who undergo surgery are infected in the process, thus putting their lives at risk. Thus the treatment for the same could be another growth driver for the hospital-acquired infection treatment market.
Global Hospital Acquired Infection Treatment Market – Restraints
There has been an increase in antimicrobial resistance, thus reducing the effectiveness of the treatment of infections. According to a report by the Global Antimicrobial Resistance and Use Surveillance System (GLASS), about 50% of resistance was reported in bacteria causing frequent bloodstream infections in hospitals. These infections are life-threatening and require last-resort antibiotics like carbapenems, but 8% of infections were reported as resistant to carbapenems, thus increasing the risk of death in patients. Thus, the resistance of the treatment options is another restraint for hospital hospital-acquired infection treatment market. Treatment of hospital-acquired infection is crucial for the health of the patients, but the development of spurious drugs for the treatment may lead to hazardous effects on the patients and worsen the rising condition making it a major market setback.
Global Hospital Acquired Infection Treatment Market – Opportunities
A rise in the geriatric population will lead to an increase in visits to hospitals, thus increasing the risk of getting a hospital-acquired infection during the treatment. This provides a chance for market expansion and creates opportunities in the global hospital-acquired infection treatment market. Improvements and developments in low-income and medium-income countries create opportunities for the key players to invest in the particular market. The rise in the cases of hospital-acquired infections and also the growth in the number of hospital admissions provide opportunities for growth in the particular market. Again, technological advancements and innovations in prevention as well as treatment of infections also provide further market opportunities.
Global Hospital-Acquired Infection Treatment Market – Geographical Insight
The market for hospital-acquired infection treatment is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for hospital-acquired infection treatment due to the presence of advanced technologies in the region. The market for hospital-acquired infection treatment in North America is distinguished by a sophisticated healthcare infrastructure, substantial healthcare spending, and a focus on technical innovation. The presence of key market players contributes to research and development in the region. Europe is another prominent market for hospital-acquired infection treatment. Countries like China, India, and Japan are at the forefront of market expansion, driven by large patient populations and a growing demand for advanced medical technologies.
Global Hospital-Acquired Infection Treatment Market – Key Development
Research Methodology: Aspects
Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.
The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.
Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.
Key phases involved in in our research process are mentioned below:
Understanding Clients’ Objectives:
Extensive Discussions and Consultations:
Industry and Market Segment Analysis:
Target Audience Understanding:
Identifying Challenges and Opportunities:
Grasping Specific Goals:
Data Collection:
Primary Research Process:
Secondary Research Process:
Data Analysis:
The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.
Transformation of Raw Data:
Utilization of Analytical Methods:
Statistical Analysis:
Qualitative Analysis Techniques:
Integrity and Validity Maintenance:
Data Validation:
The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.
Importance of Data Validation:
Scrutiny of Collected Data:
Validation Techniques:
Internal Quality Assurance Protocols:
We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Cognizance market research is continuously guiding customers around the globe towards strategies for transformational growth. Today, businesses have to innovate more than ever before, not just to survive, but to succeed in the future
© 2023 All rights Reserved. Cognizance Market Research